Ziopharm Oncology reported $3.43M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Amgen AMGN:US $ 1.33B 99M
AstraZeneca AZN:LN 268.26B 35.48B
Baxter International BAX:US $ 817M 27M
Biogen BIIB:US $ 572.6M 62.3M
Bristol Myers Squibb BMY:US $ 1.78B 46M
Corcept Therapeutics CORT:US $ 37.81M 264K
Curis CRIS:US $ 5.09M 584K
Eleven Biotherapeutics EBIO:US 8.98M 379K
Gilead Sciences GILD:US $ 1.36B 274M
GlaxoSmithKline GSK:LN 195.5B 18.5B
Immunogen IMGN:US $ 23.79M 7.14M
Intercept Pharmaceuticals ICPT:US $ 39.98M 10.02M
Intrexon XON:US $ 12.67M 6.91M
IONIS PHARMACEUT IONS:US $ 33.8M 325K
Johnson & Johnson JNJ:US $ 6.23B 288M
Karyopharm Therapeutics KPTI:US $ 37.34M 1.43M
Merk MRK:US $ 2.42B 118M
Novartis NOVN:VX 3.59B 91M
Pfizer PFE:US $ 3.2B 506M
Ptc Therapeutics PTCT:US $ 79.89M 6.62M
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M
Sangamo Biosciences SGMO:US $ 15.09M 185K
Tg Therapeutics TGTX:US $ 12.64M 7.97M
Verastem VSTM:US $ 6.51M 580K
YTE INCY:US $ 253.28M 43.69M
Ziopharm Oncology ZIOP:US $ 3.43M 76K